Can surgery beat pancreatic cancer spread? new trial aims to find out
NCT ID NCT07340151
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests whether removing both the main pancreatic tumor and small spots in the liver or lungs after chemotherapy can help patients. It includes 40 people whose cancer has spread to only a few spots. Everyone gets the same treatment: chemo first, then surgery if the cancer shrinks or stays stable. The goal is to see if this approach is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- NALIRIFOX chemotherapy (liposomal irinotecan, oxaliplatin, 5-fluorouracil, folinic acid) followed by surgery
- What this could lead to
- If successful, this could show that removing both the main tumor and limited liver or lung spots after chemotherapy improves survival for some pancreatic cancer patients.
- What could go wrong
- This is a small, early-phase trial with only 40 people and no comparison group. The cancer may still return, and surgery carries risks like infection or complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA OF THE PANCREAS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Texas Health Science Center San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart drug delivers chemo directly to pancreatic cancer cells
- Engineered T-Cells take aim at Hard-to-Treat pancreatic cancer
- Could a stomach drug help fight pancreatic cancer?
- New hope for tough pancreatic cancer? drug combo targets KRAS mutations
- Experimental vaccine combo takes on tough pancreatic cancer
- Supercharged immune cells take on Hard-to-Treat pancreatic cancer